Zoledronic acid treatment impairs protein geranyl-geranylation for biological effects in prostatic cells
2006

Effects of Zoledronic Acid on Prostate Cells

publication Evidence: moderate

Author Information

Author(s): Goffinet M, Thoulouzan M, Pradines A, Lajoie-Mazenc I, Weinbaum Carolyn, Faye JC, Séronie-Vivien S

Primary Institution: Inserm U563, Centre de Physiopathologie de Toulouse Purpan, Institut Claudius Regaud, Toulouse, France

Hypothesis

Does zoledronic acid impair protein geranyl-geranylation in prostatic cells?

Conclusion

Zoledronic acid inhibits protein geranyl-geranylation in prostatic cells, affecting their biological activity.

Supporting Evidence

  • Zoledronic acid inhibited the proliferation of all three prostatic cell lines in a dose-dependent manner.
  • The non-tumoral cell line PNT1-A was affected most by zoledronic acid treatment.
  • Geranyl-geraniol was able to reverse the inhibition of proliferation caused by zoledronic acid.

Takeaway

Zoledronic acid is a medicine that can stop certain cells in the prostate from growing by blocking a process that helps proteins work properly.

Methodology

The study used three prostatic cell lines to assess the effects of zoledronic acid on cell proliferation and protein isoprenylation.

Limitations

The exact mechanism of action of zoledronic acid in prostatic cells remains unclear.

Statistical Information

P-Value

p<0.01

Statistical Significance

p<0.01

Digital Object Identifier (DOI)

10.1186/1471-2407-6-60

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication